These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27578921)

  • 41. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diminished percentage of CD4+ T-lymphocytes expressing interleukine-2 receptor alpha in chronic brucellosis.
    Skendros P; Boura P; Chrisagis D; Raptopoulou-Gigi M
    J Infect; 2007 Feb; 54(2):192-7. PubMed ID: 16720045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
    Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
    Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
    Amarnath S; Dong L; Li J; Wu Y; Chen W
    Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
    Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
    J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
    Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
    Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
    LaRosa DF; Gelman AE; Rahman AH; Zhang J; Turka LA; Walsh PT
    Immunol Lett; 2007 Feb; 108(2):183-8. PubMed ID: 17270282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection.
    Hashempoor T; Bamdad T; Merat S; Janzamin E; Nemati L; Jabbari H; Sharifi AH; Zamini H
    Iran J Immunol; 2010 Sep; 7(3):177-85. PubMed ID: 20876988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
    Liu L; Wu G; Yao JX; Ding Q; Huang SA
    Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
    Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
    Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture.
    Silberstein E; Konduru K; Kaplan GG
    Virol J; 2009 Oct; 6():175. PubMed ID: 19860892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.